ANI Pharmaceuticals Inc logo

ANIP - ANI Pharmaceuticals Inc Share Price

$73.59 -2.9  -3.8%

Last Trade - 3:15pm

Sector
Healthcare
Size
Mid Cap
Market Cap £740.6m
Enterprise Value £856.7m
Revenue £172.1m
Position in Universe 2461st / 6399
Bullish
Bearish
Unlock ANIP Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ANIP Revenue Unlock ANIP Revenue

Net Income

ANIP Net Income Unlock ANIP Revenue

Normalised EPS

ANIP Normalised EPS Unlock ANIP Revenue

PE Ratio Range

ANIP PE Ratio Range Unlock ANIP Revenue

Dividend Yield Range

ANIP Dividend Yield Range Unlock ANIP Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ANIP EPS Forecasts Unlock ANIP Revenue
Profile Summary

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It also performs contract manufacturing for other pharmaceutical companies. Its products include both branded and generic pharmaceuticals. Its generic products include Erythromycin Ethylsuccinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Flecainide, Fluvoxamine, Hydrocortisone Enema, Methazolamide, Metoclopramide Syrup Nilutamide, Nimodipine, Opium Tincture, Oxycodone Capsules, Oxycodone Oral Solution, Propafenone and Vancomycin. Its branded products include Cortenema, Inderal LA, Lithobid, Reglan and Vancocin. Its pharmaceutical manufacturing facilities are located in Baudette, Minnesota.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Incorporated April 11, 2001
Public Since December 7, 1994
No. of Shareholders: 100
No. of Employees: 299
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Market
Shares in Issue 12,097,134
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ANIP Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ANIP
Upcoming Events for ANIP
Similar to ANIP
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.